These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 21684856)

  • 1. Self-reported symptoms among HIV-lnfected patients on highly active antiretroviral therapy in the ATHENA cohort in The Netherlands.
    de Boer IM; Prins JM; Sprangers MA; Smit C; Nieuwkerk PT
    HIV Clin Trials; 2011; 12(3):161-70. PubMed ID: 21684856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life and survival among HIV-infected patients receiving highly active antiretroviral therapy: a study of patients in the AIDS Therapy Evaluation in the Netherlands (ATHENA) Cohort.
    de Boer-van der Kolk IM; Sprangers MA; Prins JM; Smit C; de Wolf F; Nieuwkerk PT
    Clin Infect Dis; 2010 Jan; 50(2):255-63. PubMed ID: 20014949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased virological failure in naive HIV-1-infected patients taking lamivudine compared with emtricitabine in combination with tenofovir and efavirenz or nevirapine in the Dutch nationwide ATHENA cohort.
    Rokx C; Fibriani A; van de Vijver DA; Verbon A; Schutten M; Gras L; Rijnders BJ;
    Clin Infect Dis; 2015 Jan; 60(1):143-53. PubMed ID: 25273080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporary antiretroviral treatment during primary HIV-1 infection has a positive impact on health-related quality of life: data from the Primo-SHM cohort study.
    Grijsen M; Koster G; van Vonderen M; van Kasteren M; Kootstra G; Steingrover R; de Wolf F; Prins J; Nieuwkerk P;
    HIV Med; 2012 Nov; 13(10):630-5. PubMed ID: 22533544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life and associated factors in people with HIV: an Irish cohort study.
    George S; Bergin C; Clarke S; Courtney G; Codd MB
    Health Qual Life Outcomes; 2016 Aug; 14(1):115. PubMed ID: 27495166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of health-related quality of life in HIV-infected patients.
    Murri R; Fantoni M; Del Borgo C; Visona R; Barracco A; Zambelli A; Testa L; Orchi N; Tozzi V; Bosco O; Wu AW
    AIDS Care; 2003 Aug; 15(4):581-90. PubMed ID: 14509872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurocognitive impairment influences quality of life in HIV-infected patients receiving HAART.
    Tozzi V; Balestra P; Murri R; Galgani S; Bellagamba R; Narciso P; Antinori A; Giulianelli M; Tosi G; Fantoni M; Sampaolesi A; Noto P; Ippolito G; Wu AW
    Int J STD AIDS; 2004 Apr; 15(4):254-9. PubMed ID: 15075020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life of HIV-infected adults receiving combination antiretroviral therapy in Addis Ababa.
    Mekuria LA; Sprangers MA; Prins JM; Yalew AW; Nieuwkerk PT
    AIDS Care; 2015; 27(8):934-45. PubMed ID: 25782603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life outcomes in HIV-infected patients starting different combination regimens in a randomized multinational trial: the INITIO-QoL substudy.
    Bucciardini R; Fragola V; Massella M; Polizzi C; Mirra M; Goodall R; Carey D; Hudson F; Zajdenverg R; Floridia M;
    AIDS Res Hum Retroviruses; 2007 Oct; 23(10):1215-22. PubMed ID: 17961107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [HIV-1 therapy in the Netherlands; virological and immunological response to antiretroviral therapy].
    Jambroes M; Weverling GJ; Reiss P; Danner SA; Jurriaans S; ten Veen JH; van der Ende ME; Schutten M; Schneider MM; Schuurman R; Mulder JW; Kroes AC; Lange JM; de Wolf F;
    Ned Tijdschr Geneeskd; 2001 Aug; 145(33):1591-7. PubMed ID: 11534377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of HIV type 1 subtype on virological and immunological response to combination antiretroviral therapy: evidence for a more rapid viral suppression for subtype A than subtype B-infected Greek individuals.
    Paraskevis D; Touloumi G; Bakoyannis G; Paparizos V; Lazanas M; Gargalianos P; Chryssos G; Antoniadou A; Psichogiou M; Panos G; Katsarou O; Sambatakou H; Kordossis T; Hatzakis A;
    AIDS Res Hum Retroviruses; 2013 Mar; 29(3):461-9. PubMed ID: 23034083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly active antiretroviral treatment (HAART) and health-related quality of life in naive and pretreated HIV-infected patients.
    Casado A; Consiglio E; Podzamczer D; Badia X
    HIV Clin Trials; 2001; 2(6):477-83. PubMed ID: 11742436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral treatment and quality of life in Africans living with HIV: 12-month follow-up in Burkina Faso.
    Jaquet A; Garanet F; Balestre E; Ekouevi DK; Azani JC; Bognounou R; Dah E; Kondombo JC; Dabis F; Drabo J
    J Int AIDS Soc; 2013 Dec; 16(1):18867. PubMed ID: 24369739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life of people living with HIV followed up in hospitals in France: comparing trends and correlates between 2003 and 2011 (ANRS-VESPA and VESPA2 national surveys).
    Douab T; Marcellin F; Vilotitch A; Protopopescu C; Préau M; Suzan-Monti M; Sagaon-Teyssier L; Lert F; Carrieri MP; Dray-Spira R; Spire B;
    AIDS Care; 2014; 26 Suppl 1():S29-40. PubMed ID: 24731158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term response to combination antiretroviral therapy in HIV-infected children in the Netherlands registered from 1996 to 2012.
    Cohen S; Smit C; van Rossum AM; Fraaij PL; Wolfs TF; Geelen SP; Schölvinck EH; Warris A; Scherpbier HJ; Pajkrt D;
    AIDS; 2013 Oct; 27(16):2567-75. PubMed ID: 23842124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with virological response in HIV-infected patients failing antiretroviral therapy: a prospective cohort study.
    Fournier S; Chaffaut C; Maillard A; Loze B; Lascoux C; Gérard L; Timsit J; David F; Bergmann JF; Oksenhendler E; Sereni D; Chevret S; Molina JM
    HIV Med; 2005 Mar; 6(2):129-34. PubMed ID: 15807719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life, depression and fatigue among persons co-infected with HIV and hepatitis C: outcomes from a population-based cohort.
    Braitstein P; Montessori V; Chan K; Montaner JS; Schechter MT; O'Shaughnessy MV; Hogg RS
    AIDS Care; 2005 May; 17(4):505-15. PubMed ID: 16036236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Which method of adherence measurement is most suitable for daily use to predict virological failure among immigrant and non-immigrant HIV-1 infected patients?
    Nellen JF; Nieuwkerk PT; Burger DM; Wibaut M; Gras LA; Prins JM
    AIDS Care; 2009 Jul; 21(7):842-50. PubMed ID: 20024740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study).
    Di Giambenedetto S; Fabbiani M; Colafigli M; Ciccarelli N; Farina S; Sidella L; D'Avino A; Mondi A; Cingolani A; Tamburrini E; Murri R; Navarra P; Cauda R; De Luca A
    J Antimicrob Chemother; 2013 Jun; 68(6):1364-72. PubMed ID: 23372058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion.
    Laurichesse JJ; Persoz A; Theodorou I; Rouzioux C; Delfraissy JF; Meyer L
    HIV Med; 2007 May; 8(4):213-9. PubMed ID: 17461848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.